• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内皮生长因子作为癌症血管生成的关键介质。

VEGF as a key mediator of angiogenesis in cancer.

作者信息

Carmeliet Peter

机构信息

Center for Transgene Technology and Gene Therapy, Flander's Interuniversity Institute for Biotechnology, University of Leuven, Leuven, Belgium.

出版信息

Oncology. 2005;69 Suppl 3:4-10. doi: 10.1159/000088478. Epub 2005 Nov 21.

DOI:10.1159/000088478
PMID:16301830
Abstract

Vascular endothelial growth factor (VEGF) is a homodimeric glycoprotein with a molecular weight of approximately 45 kDa. It is the key mediator of angiogenesis (the formation of new blood vessels), and binds two VEGF receptors (VEGF receptor-1 and VEGF receptor-2), which are expressed on vascular endothelial cells. In healthy humans, VEGF promotes angiogenesis in embryonic development and is important in wound healing in adults. VEGF is the key mediator of angiogenesis in cancer, in which it is up-regulated by oncogene expression, a variety of growth factors and also hypoxia. Angiogenesis is essential for cancer development and growth: before a tumor can grow beyond 1-2 mm, it requires blood vessels for nutrients and oxygen. The production of VEGF and other growth factors by the tumor results in the 'angiogenic switch', where new vasculature is formed in and around the tumor, allowing it to grow exponentially. Tumor vasculature formed under the influence of VEGF is structurally and functionally abnormal. Blood vessels are irregularly shaped, tortuous, have dead ends and are not organized into venules, arterioles and capillaries. They are also leaky and hemorrhagic, which leads to high interstitial pressure. These characteristics mean that tumor blood flow is suboptimal, resulting in hypoxia and further VEGF production. This central role of VEGF in the production of tumor vasculature makes it a rational target for anticancer therapy.

摘要

血管内皮生长因子(VEGF)是一种分子量约为45 kDa的同型二聚体糖蛋白。它是血管生成(新血管形成)的关键介质,可与两种血管内皮生长因子受体(血管内皮生长因子受体-1和血管内皮生长因子受体-2)结合,这两种受体在血管内皮细胞上表达。在健康人体内,血管内皮生长因子在胚胎发育过程中促进血管生成,对成年人伤口愈合也很重要。血管内皮生长因子是癌症中血管生成的关键介质,在癌症中它会因癌基因表达、多种生长因子以及缺氧而上调。血管生成对癌症的发展和生长至关重要:在肿瘤生长超过1-2毫米之前,它需要血管来提供营养和氧气。肿瘤产生的血管内皮生长因子和其他生长因子会导致“血管生成开关”,肿瘤内部和周围会形成新的脉管系统,使其呈指数级生长。在血管内皮生长因子影响下形成的肿瘤脉管系统在结构和功能上都不正常。血管形状不规则、蜿蜒曲折、有盲端,且未组织成小静脉、小动脉和毛细血管。它们还具有渗漏性和出血性,这会导致高间质压力。这些特征意味着肿瘤血流不理想,导致缺氧并进一步产生血管内皮生长因子。血管内皮生长因子在肿瘤脉管系统生成中的核心作用使其成为抗癌治疗的合理靶点。

相似文献

1
VEGF as a key mediator of angiogenesis in cancer.血管内皮生长因子作为癌症血管生成的关键介质。
Oncology. 2005;69 Suppl 3:4-10. doi: 10.1159/000088478. Epub 2005 Nov 21.
2
VEGF as a therapeutic target in cancer.血管内皮生长因子作为癌症的治疗靶点。
Oncology. 2005;69 Suppl 3:11-6. doi: 10.1159/000088479. Epub 2005 Nov 21.
3
Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.血管内皮生长因子(VEGF)及其受体在肿瘤血管生成和恶性肿瘤中的表达
Integr Cancer Ther. 2005 Dec;4(4):315-21. doi: 10.1177/1534735405282557.
4
Role of the VEGF/VEGFR axis in cancer biology and therapy.VEGF/VEGFR 轴在癌症生物学和治疗中的作用。
Adv Cancer Res. 2012;114:237-67. doi: 10.1016/B978-0-12-386503-8.00006-5.
5
Angiogenesis--a new target for future therapy.血管生成——未来治疗的新靶点。
Vascul Pharmacol. 2006 May;44(5):265-74. doi: 10.1016/j.vph.2006.01.005. Epub 2006 Mar 20.
6
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.血管内皮生长因子通路在肿瘤生长和血管生成中的作用。
J Clin Oncol. 2005 Feb 10;23(5):1011-27. doi: 10.1200/JCO.2005.06.081. Epub 2004 Dec 7.
7
Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.抑制血管内皮生长因子(VEGF)作为一种癌症治疗的新方法。
Medicina (B Aires). 2000;60 Suppl 2:41-7.
8
Current insights on the biology and clinical aspects of VEGF regulation.关于血管内皮生长因子(VEGF)调控的生物学及临床方面的当前见解。
Vasc Endovascular Surg. 2008;42(6):517-30. doi: 10.1177/1538574408322755. Epub 2008 Sep 17.
9
Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.使用GFA-116阻断血管生成和肿瘤发生,GFA-116是一种抑制血管内皮生长因子与其受体结合的合成分子。
Cancer Res. 2004 May 15;64(10):3586-92. doi: 10.1158/0008-5472.CAN-03-2673.
10
Vascular endothelial growth factor (VEGF) signaling in tumor progression.血管内皮生长因子(VEGF)信号传导在肿瘤进展中的作用
Crit Rev Oncol Hematol. 2007 Jun;62(3):179-213. doi: 10.1016/j.critrevonc.2007.01.006. Epub 2007 Feb 26.

引用本文的文献

1
Partial Remission Without Recurrence in a 9-Year-Old Golden Retriever with Nasal Carcinoma Treated with Prednisolone/Chlorambucil Metronomic Combination Therapy: A Case Report and Literature Review of Molecular Mechanisms.泼尼松龙/苯丁酸氮芥节拍联合疗法治疗9岁金毛猎犬鼻癌获部分缓解且无复发:病例报告及分子机制文献综述
Curr Issues Mol Biol. 2025 Aug 15;47(8):660. doi: 10.3390/cimb47080660.
2
PKM2 regulates angiogenic activation via ANGPT2 in endothelial cells.丙酮酸激酶M2通过血管生成素2调节内皮细胞中的血管生成激活。
Sci Rep. 2025 Aug 26;15(1):31448. doi: 10.1038/s41598-025-17147-2.
3
Conversion of natural cytokine receptors into orthogonal synthetic biosensors.
将天然细胞因子受体转化为正交合成生物传感器。
Nat Chem Biol. 2025 Aug 22. doi: 10.1038/s41589-025-01986-1.
4
Assessment of serum vascular endothelial growth factor, nitric oxide and asymmetric dimethyl arginine levels in non-small cell lung cancer.非小细胞肺癌患者血清血管内皮生长因子、一氧化氮及不对称二甲基精氨酸水平的评估
North Clin Istanb. 2025 Jan 29;12(1):45-54. doi: 10.14744/nci.2024.38991. eCollection 2025.
5
Engineering stem cell exosomes promotes the survival of multi-territory perforator flap in diabetes via regulating anti-inflammatory and angiogenesis.工程化干细胞外泌体通过调节抗炎和血管生成促进糖尿病中多区域穿支皮瓣的存活。
Regen Biomater. 2025 Jul 24;12:rbaf075. doi: 10.1093/rb/rbaf075. eCollection 2025.
6
RNA-seq analysis identifies key genes enhancing hoof strength to withstand barefoot racing in Standardbred trotters.RNA测序分析确定了增强蹄部力量以承受标准赛马快步马赤脚赛跑的关键基因。
BMC Genomics. 2025 Aug 18;26(1):751. doi: 10.1186/s12864-025-11814-4.
7
Isorhamnetin: Reviewing Recent Developments in Anticancer Mechanisms and Nanoformulation-Driven Delivery.异鼠李素:抗癌机制及纳米制剂驱动递送的最新进展综述
Int J Mol Sci. 2025 Jul 30;26(15):7381. doi: 10.3390/ijms26157381.
8
Virus-human chromatin interactions reorganise 3D genome and hijack KDM5B for promoting metastasis in nasopharyngeal carcinoma.病毒与人类染色质相互作用重塑三维基因组并劫持KDM5B以促进鼻咽癌转移。
Nat Commun. 2025 Aug 4;16(1):7149. doi: 10.1038/s41467-025-61597-1.
9
Characterization of Factors Associated with Tissue Immunity, Cellular Activity and Angiogenesis in Children with Unilateral Cleft Lip and Palate Before and During Primary Dentition: A Comparative Cross-Sectional Study.乳牙列期及乳牙列期期间单侧唇腭裂患儿组织免疫、细胞活性和血管生成相关因素的特征:一项比较性横断面研究
J Clin Med. 2025 Jul 12;14(14):4952. doi: 10.3390/jcm14144952.
10
Macrophage induces angiogenesis via HIF signaling in denervated muscle following nerve injury.巨噬细胞通过低氧诱导因子信号通路在神经损伤后的失神经肌肉中诱导血管生成。
Sci Rep. 2025 Jul 19;15(1):26239. doi: 10.1038/s41598-025-07536-y.